Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics

revised

  • 122(1):198
AMERICAN ACADEMY OF PEDIATRICS

Cholesterol in Childhood

Committee on Nutrition
Pediatrics January 1998, 101 (1) 141-147; DOI: https://doi.org/10.1542/peds.101.1.141
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading

This article has a correction. Please see:

  • ERRATUM - April 01, 1998
Download PDF

Abstract

This updated statement reviews the scientific justification for the recommendations of dietary changes in all healthy children (a population approach) and a strategy to identify and treat children who are at highest risk for the development of accelerated atherosclerosis in early adult life (an individualized approach). Although the precise fraction of risk for future coronary heart disease conveyed by elevated cholesterol levels in childhood is unknown, clear epidemiologic and experimental evidence indicates that the risk is significant. Diet changes that lower fat, saturated fat, and cholesterol intake in children and adolescents can be applied safely and acceptably, resulting in improved plasma lipid profiles that, if carried into adult life, have the potential to reduce atherosclerotic vascular disease.

  • Abbreviations:
    LDL =
    low-density lipoprotein •
    HDL =
    high-density lipoprotein
  • Although the focus of this statement by the Committee on Nutrition is on cholesterol levels in children, other risk factors for atherosclerosis originate in childhood and should be addressed with equal attention. Specifically, smoking should be discouraged, hypertension should be identified and treated, obesity should be avoided and reduced, regular exercise should be encouraged, and diabetes mellitus should be identified and treated.1

    This statement, for the most part, is in concert with statements of other experts and expert panels, including the National Cholesterol Education Program, the American Heart Association's Council on Cardiovascular Disease in the Young and Committee on Nutrition, the US Department of Agriculture and the US Department of Health and Human Services Dietary Guidelines for Americans, the US Surgeon General, the National Research Council, and the National Cancer Institute.

    DIET AND ATHEROSCLEROSIS

    Studies in animals have demonstrated that high blood cholesterol levels promote atherosclerosis.2-4 Atherosclerosis develops in many species fed diets that raise the total and low-density lipoprotein (LDL)–cholesterol levels. Vascular fatty streaks and fibrous plaques develop in adolescent nonhuman primates fed diets high in saturated fatty acids and cholesterol.5 6 In monkeys with severe atherosclerosis, regression of the process occurs when the blood cholesterol level is lowered with diet and drugs.2 7 8

    In adults, the major nutritional determinant of differences in serum cholesterol levels between countries appears to be the proportion of saturated fat in the diet.9-11 This also is observed in childhood populations.11-13 Total blood cholesterol levels in children vary geographically. In countries such as the Philippines, Italy, and Ghana, saturated fat constitutes approximately ≤10% dietary intake, and the serum cholesterol level in boys 8 to 9 years of age is generally below 160 mg/dL.13-15 In boys from countries such as the Netherlands, Finland, and the United States, the saturated fat intake varies from 13.5% to 17.7% of energy intake, and serum cholesterol levels are generally >160 mg/dL. Although blood cholesterol levels are lowest in countries in which nutrition is not optimal and growth is delayed, there are many industrialized countries in which children have lower cholesterol levels than children in the United States and in which normal growth is maintained (eg, Portugal, Israel, and Italy). A range of serum cholesterol levels is found in industrialized countries, with the United States in the top half of the range.13 15-23

    CLINICAL TRIALS

    Clinical trials in adult populations have shown that lowering cholesterol levels reduces coronary risk.2 24-26Aggregate analysis of many clinical trials shows that lowering cholesterol levels by diet or drugs and by primary or secondary prevention reduces fatal and nonfatal myocardial infarction.27 Initially, some controversy occurred about the effectiveness of lowering cholesterol levels because a number of trials did not find a significant reduction in total mortality after treatment to lower the cholesterol level.2 These findings have been clarified recently by several studies with large samples of subjects and of long duration showing a decrease not only in the incidence of coronary heart disease but also in mortality from all causes.28 29

    In addition, the Dietary Intervention Study in Children, a recent study of the safety and efficacy of lower fat diets in pubertal children, was reported by a collaborative multicenter group. In this study of 663 children 8 to 10 years of age who were followed for 3 years, an intervention group receiving a diet with 28% of calories from total fat, ∼10% of calories from saturated fat, and 95 mg per day of cholesterol was compared with a group that consumed 33% to 34% of calories as total fat, 12.7% of calories as saturated fat, and 112 mg per day of cholesterol. There were no differences in height, weight, or serum ferritin levels in the two groups, and the intervention group had significant, but modestly lower, levels of LDL–cholesterol levels and maintained psychologic well-being.30

    SIGNIFICANCE OF BLOOD CHOLESTEROL LEVELS IN CHILDREN AND ADOLESCENTS

    High blood cholesterol levels clearly play a role in the development of premature coronary heart disease in adults. This has been established by many laboratory, clinical, pathological, and epidemiologic studies. It has also been shown that lowering blood cholesterol levels in adults results in a significant lowering of coronary heart disease rates and mortality. Because no long-term studies of the relationship of blood cholesterol levels measured in childhood to coronary heart disease in later life have been conducted, the relationship of childhood cholesterol levels to the atherosclerotic process must be inferred from less direct evidence.

    These lines of evidence are summarized as follows:

    1. Compared with their counterparts in many other countries, US children and adolescents have higher blood cholesterol levels and higher intakes of saturated fatty acids and cholesterol, and US adults have higher rates of coronary heart disease morbidity and mortality.13 15

    2. Autopsy studies demonstrate that early coronary atherosclerosis or precursors of atherosclerosis often begin in childhood and adolescence and are related to high serum total cholesterol levels, LDL–cholesterol plus very low-density lipoprotein–cholesterol levels, and low high-density lipoprotein levels.

    3. Children and adolescents with elevated serum cholesterol levels, particularly LDL–cholesterol levels, often come from families in which there is a high incidence of coronary heart disease in the adult relatives.32 33

    4. A strong familial aggregation of total, LDL-, and HDL–cholesterol levels exists in children and parents.34 35 Familial aggregation of blood cholesterol levels results because of shared environments and genetic factors.36 The monogenetic factors that cause high cholesterol levels include familial hypercholesterolemia and familial-combined hypercholesterolemia. Polygenic disorders that result from the expression of a number of genes, each with a small but additional effect, combined with environmental contributions such as a diet high in saturated fat and cholesterol are likely the most frequent causes of high cholesterol levels during childhood.37 38

    5. Children and adolescents with high cholesterol levels are more likely than the general population to have high levels as adults.39-45 However, a substantial number of children with high cholesterol levels become adults with desirable cholesterol levels without intervention.46

    STRATEGIES TO LOWER CHOLESTEROL LEVELS IN CHILDREN AND ADOLESCENTS

    To lower blood cholesterol levels in children and adolescents, two complementary approaches are recommended: a population approach and an individualized approach.

    The Population Approach

    The population approach is designed as the primary means for preventing coronary heart disease. It aims to lower the average level of blood cholesterol in all children and adolescents through population-wide changes in nutrient intake and eating patterns. These recommendations are directed to groups that influence the eating patterns of children and adolescents, including schools, health professionals, government agencies, the food industry, and the mass media. The advantage of this approach is that even a small reduction of the mean total and LDL–cholesterol levels in children and adolescents, if carried into adult life, could decrease substantially the incidence of coronary heart disease.

    The US Department of Agriculture 1987 to 1988 Food Consumption Survey indicated that children and adolescents consume 35% to 36% of calories from total fat; 14% from saturated fat, and 193 to 296 mg per day of cholesterol.47 48 More recent US population-based data from the National Health and Nutrition Examination Survey III for persons 2 to 19 years of age indicate that mean intakes of total fat and saturated fat are 34% and 12%, respectively, and the mean cholesterol intake is ∼270 mg per day.49

    Nutrient Recommendations

    No restriction of fat or cholesterol is recommended for infants <2 years when rapid growth and development require high energy intakes. A precise percentage of dietary intake from fat that supports normal growth and development while maximally reducing atherosclerosis risk is unknown. Therefore, a range of appropriate values, averaged over several days for a child or adolescent, is recommended based on the scientific information available. Because concerns have been expressed that some parents and their children may overinterpret the need to restrict their fat intakes, a lower limit of fat intake is suggested by this Committee. The Committee recognizes that children 2 to 5 years of age are selective in their food choices. After 2 years of age, children and adolescents should gradually adopt a diet that, by ∼5 years of age, contains ≤30% of calories and ≤20% from fat. As they begin to consume fewer calories from fat, children should replace these calories by eating more grain products, fruits, vegetables, low-fat milk products or other calcium-rich foods, beans, lean meat, poultry, fish, or other protein-rich foods. These recommendations are for average intakes over several days, so that if foods high in total fat, saturated fat, and cholesterol are eaten, they can be compensated for by eating less of these nutrients at other times. Because no single food item provides all the essential nutrients in the amounts needed, choosing a wide variety of food from all the food groups will ensure an adequate diet.

    Specific nutrient recommendations are as follows: 1) nutritional adequacy should be achieved by eating a wide variety of foods; and 2) caloric intake should be adequate to support growth and development and to reach or maintain desirable body weight.

    For a child or adolescent (2 to 18 years of age), the following pattern of nutrient intake is recommended: 1) saturated fatty acids <10% of total calories; 2) total fat over several days of ≤30% of total calories and no less than 20% of total calories; and 3) dietary cholesterol <300 mg per day.

    Because saturated fatty acids raise blood cholesterol levels,50 a major emphasis should be placed on reducing saturated fat intake to <10% of calories. A sufficiently low saturated fat intake can be achieved with a total fat intake of ∼30% of calories from fat. A lower fat intake is usually not necessary and, for some children and adolescents, may make it difficult to provide enough calories and minerals for optimal growth and development.

    THE INDIVIDUALIZED APPROACH

    The individualized approach to lowering cholesterol levels calls on the cooperative effort of health care professionals to identify and treat children and adolescents at highest risk of having high blood cholesterol levels as adults and increased risk of coronary heart disease.

    Selective Screening

    Figures 1 and2 present the algorithms for selective screening.

    Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Risk assessment. Positive family history is defined as a history of premature (≤55 years of age) cardiovascular disease in a parent or grandparent (from the National Cholesterol Education Program52).

    Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Classification, education, and followup based on low-density lipoprotein–cholesterol (from the National Cholesterol Education Program52). HDL indicates high-density lipoprotein; LDL, low-density lipoprotein.

    Children and adolescents who have a family history of premature cardiovascular disease or have at least one parent with a high blood cholesterol level are at increased risk of having high blood cholesterol levels as adults and increased risk of coronary heart disease and, therefore, are recommended for selective screening in the context of regular health care. This focus is supported by strong evidence of familial aggregation of coronary heart disease, high blood cholesterol levels, and other risk factors.

    The following are specific recommendations for selective screening of children and adolescents in the context of their continuing health care.

    1. Screen children and adolescents whose parents or grandparents, at ≤55 years of age, underwent diagnostic coronary arteriography and were found to have coronary atherosclerosis. This includes those who have undergone balloon angioplasty or coronary artery bypass surgery.

    2. Screen children and adolescents whose parents or grandparents, at ≤55 years of age, had a documented myocardial infarction, angina pectoris, peripheral vascular disease, cerebrovascular disease, or sudden cardiac death.

    3. Screen the offspring of a parent with an elevated blood cholesterol level (240 mg/dL or higher).

    4. For children and adolescents whose parental history is unobtainable, particularly for those with other risk factors, physicians may choose to measure cholesterol levels to identify those in need of nutritional and medical advice.

    Optional cholesterol testing by practicing physicians may be appropriate for children who are judged to be at higher risk for coronary heart disease independent of family history (Table1). For example, adolescents who smoke, consume excessive amounts of saturated fats and cholesterol, or are overweight may also be tested at the discretion of their physician. For parents who do not know their cholesterol levels, pediatricians should strongly encourage them to have their levels measured.

    View this table:
    • View inline
    • View popup
    Table 1.

    Other Risk Factors That Contribute to Earlier Onset of Coronary Heart Disease

    What Should Be Measured

    The focus of the individualized approach is to detect and treat the child or adolescent with hypercholesterolemia whose elevated LDL–cholesterol level is likely to indicate increased risk in adulthood. The screening protocol varies according to the reason for testing. This protocol is suggested to limit the need for more sophisticated analyses. If screening is performed because a parent has a cholesterol higher than 240 mg/dL, the initial test should be a measurement of total cholesterol. If the child's level is higher than 200 mg/dL, a fasting lipoprotein analysis should be obtained to measure HDL–cholesterol and LDL–cholesterol levels. If the total cholesterol is borderline (170 to 199 mg/dL), a second measurement should be obtained and averaged with the first result. If the average is borderline or high, a fasting lipoprotein analysis should be obtained.

    If the patient is being tested because of a documented family history of premature cardiovascular disease, the initial test should be a lipoprotein analysis that requires a 12-hour fast to obtain accurate triglyceride levels, which are necessary for the computation of LDL–cholesterol levels. The acceptable borderline and high levels for total and LDL–cholesterol are given in Table2.

    View this table:
    • View inline
    • View popup
    Table 2.

    Classification of Total and LDL–Cholesterol Levels in Children and Adolescents From Families With Hypercholesterolemia or Premature Cardiovascular Disease

    Management

    Because there is considerable variability in some children, once a lipoprotein analysis is obtained, it should be repeated so that an average LDL–cholesterol level can be calculated. The average LDL–cholesterol level determines the steps for risk assessment and treatment. Follow-up of the averaged LDL–cholesterol determinations is as follows:

    1.  Acceptable LDL–cholesterol level (<110 mg/dL)—Provide education on the eating pattern recommended for all children and adolescents and on other risk factors; repeat lipoprotein analysis in 5 years.

    2.  Borderline LDL–cholesterol (110 to 129 mg/dL)—Provide advice about risk factors for cardiovascular disease; initiate the American Heart Association Step-One diet and other risk factor intervention; reevaluate in 1 year.

    3.  High LDL–cholesterol (≥130 mg/dL)—Examine for secondary causes (thyroid, liver, and renal disorders) and familial disorders, screen all family members, initiate Step-One diet, followed by the Step-Two diet, if necessary.

    Step-One and Step-Two Diets

    The Step-One diet calls for the same nutrient intake recommended for the population approach to lower cholesterol levels, ie, ≤30% and no less than 20% of calories from total fat; <10% of total calories from saturated fat; ≤10% of calories from polyunsaturated fat; and no more than 300 mg per day of cholesterol. What makes the diet therapeutic is prescription in a medical setting with monitoring and follow-up by a health professional. If careful adherence to this diet for at least 3 months does not result in a lower LDL–cholesterol level to the acceptable range, the Step-Two diet should be prescribed. Often children who have been determined to have high LDL–cholesterol levels have instituted a diet similar to the Step-One diet and require counseling to adopt the Step-Two diet.51

    The Step-Two diet requires detailed assessment of current eating patterns and instruction by a physician, registered dietitian, registered nurse, nutritionist, or other appropriately trained health professional. It aims to induce an eating pattern that includes no more than 30% and no less than 20% of calories from total fat; <7% of total calories from saturated fat; ≤10% of calories from polyunsaturated fat; and no more than 200 mg per day of cholesterol. This eating pattern requires careful planning to ensure adequacy of nutrients, vitamins, and minerals, and often requires the services of a registered dietitian or other qualified nutrition professional.

    Drug Therapy

    Drug therapy should be considered only for children >10 years of age after an adequate trial of diet therapy (for 6 to 12 months) and whose LDL–cholesterol level remains ≥190 mg/dLor whose LDL–cholesterol level remains ≥160 mg/dLand there is a family history of premature cardiovascular disease (≤55 years of age) or two or more other risk factors (Table 1) are present in the child or adolescent after vigorous attempts have been made to control these risk factors.

    The recommended drugs for the treatment of hypercholesterolemia and high LDL–cholesterol levels in children are the bile acid sequestrants cholestyramine and colestipol, which bind bile acids in the intestinal lumen. They have documented efficacy, relative freedom from adverse effects, and are apparently safe when administered to children. Other pharmacologic agents are not recommended for routine use in children and adolescents except in consultation with a lipid specialist.

    CONCLUSION

    To promote lower cholesterol levels in all healthy children (2 to 18 years of age) in the United States, the following pattern of nutrient intake is recommended.

    1. Saturated fatty acids <10% of total calories.

    2. Total fat over several days of no more than 30% of total calories and no less than 20% of total calories.

    3. Dietary cholesterol <300 mg per day.

    Pediatricians should identify children at highest risk for the development of accelerated atherosclerosis by screening cholesterol levels in children who have a parental or grandparental history (≤55 years of age) of a documented myocardial infarction, angina pectoris, peripheral vascular disease, cerebrovascular disease, or sudden cardiac death, or a parent with a high blood cholesterol level (≥240 mg/dL). In addition, for children and adolescents whose parental history is unobtainable, particularly those with other risk factors, physicians may measure cholesterol levels to determine those in need of nutritional and medical advice.

    A precise percentage of dietary intake from fat that supports normal growth and development while maximally reducing atherosclerosis risk is unknown. Therefore, a range of appropriate values, averaged over several days for a child or adolescent, is recommended based on the scientific information available.

    Committee on Nutrition, 1996 to 1997

    William J. Klish, MD, Chair

    Susan S. Baker, MD

    William J. Cochran, MD

    Carlos A. Flores, MD

    Michael K. Georgieff, MD

    Marc S. Jacobson, MD

    Alan Lake, MD

    Liaison Representatives

    Donna Blum

    US Department of Agriculture

    Suzanne S. Harris, PhD

    International Life Sciences Institute

    Van S. Hubbard, MD

    National Institute of Diabetes & Digestive & Kidney  Diseases

    Ephraim Levin, MD

    National Institute of Child Health & Human  Development

    Ann Prendergast, RD, MPH

    Maternal & Child Health Bureau

    Alice E. Smith, MS, RD

    American Dietetic Association

    Elizabeth Yetley, PhD

    Food and Drug Administration

    AAP Section Liaison

    Ronald M. Lauer, MD

    Section on Cardiology

    Footnotes

    • Material in this statement is adapted from the Report of the Expert Panel on Blood Cholesterol in Children and Adolescentsof the National Cholesterol Education Program.52It has been modified to reflect additional considerations of the Committee on Nutrition of the American Academy of Pediatrics.

    • The recommendations in this statement do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

    REFERENCES

    1. ↵
      1. Strong WB,
      2. Deckelbaum RJ,
      3. Gidding SS,
      4. et al.
      (1992) Integrated cardiovascular health promotion in childhood: a statement for health professionals from the Subcommittee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 85:1638–1650.
      OpenUrlFREE Full Text
    2. ↵
      1. LaRosa JC,
      2. Hunninghake D,
      3. Bush D,
      4. et al.
      (1990) The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Circulation. 81:1721–1733.
      OpenUrlFREE Full Text
    3. ↵
      1. Bullock BC,
      2. Lehner ND,
      3. Clarkson TB,
      4. Feldner MA,
      5. Wagner WD,
      6. Lofland HB
      (1975) Comparative primate atherosclerosis. I. Tissue cholesterol concentration and pathologic anatomy. Exp Mol Pathol. 22:151–175.
      OpenUrlCrossRefPubMed
    4. ↵
      1. Taylor CB,
      2. Patton DE,
      3. Cox GE
      (1963) Atherosclerosis in rhesus monkeys. VI. Fatal myocardial infarction in a monkey fed fat and cholesterol. Arch Pathol. 76:404–412.
      OpenUrlPubMed
    5. ↵
      1. Clarkson TB,
      2. Bond MG,
      3. Bullock BC,
      4. Marzetta CA
      (1981) A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dL. Exp Mol Pathol. 34:345–368.
      OpenUrlCrossRefPubMed
    6. ↵
      1. Clarkson TB,
      2. Bond MG,
      3. Bullock BC,
      4. McLaughlin KJ,
      5. Sawyer JK
      (1984) A study of atherosclerosis regression in Macaca mulatta. V. Changes in abdominal aorta and carotid and coronary arteries from animals with atherosclerosis induced for 38 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dL. Exp Mol Pathol. 41:96–118.
      OpenUrlCrossRefPubMed
    7. ↵
      1. Armstrong ML
      (1976) Regression of atherosclerosis. Atherosclerosis Rev. 1:137–182.
      OpenUrl
    8. ↵
      1. Malinow MR
      (1983) Experimental models of atherosclerosis regression. Atherosclerosis. 48:105–118.
      OpenUrlCrossRefPubMed
    9. ↵
      1. Conference on the health effects of blood lipids: optimal distributions for populations
      (1979) Workshop report: epidemiological section, American Health Foundation, April 11 and 12, 1979. Prev Med. 8:612–678.
      OpenUrlCrossRefPubMed
    10. ↵
      1. Coronary heart disease in seven countries
      (1970) Circulation. 41:I1–I195.
      OpenUrlCrossRefPubMed
    11. ↵
      1. Knuiman JT,
      2. West CE,
      3. Katan MB,
      4. Hautvast JG
      (1987) Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake. Arteriosclerosis. 7:612–619.
      OpenUrlAbstract/FREE Full Text
    12. ↵
      1. Blackburn H
      (1983) Diet and atherosclerosis: epidemiologic evidence and public health implications. Prev Med. 12:2–10.
      OpenUrlCrossRefPubMed
    13. ↵
      1. Knuiman JT,
      2. Westenbrink S,
      3. van der Heyden L,
      4. et al.
      (1983) Determinants of total and high density lipoprotein cholesterol in boys from Finland, the Netherlands, Italy, the Philippines and Ghana with special reference to diet. Hum Nutr Clin Nutr 37:237–254.
      OpenUrlPubMed
    14. ↵
      Carroll MD, Abraham S, Dresser CM. Dietary intake source data: United States, 1976–80. Vital health stat 11. 1983; 231
    15. ↵
      Abraham S, Johnson CL, Carroll MD. Total Serum Cholesterol Levels of Children 4–17 Years: United States, 1971–74. Hyattsville, MD: US Dept of Health, Education, and Welfare publication PHS 78-1655; 1978
    16. ↵
      1. Knuiman JT,
      2. Hermus RJ,
      3. Hautvast JG
      (1980) Serum total and high density lipoprotein (HDL) cholesterol concentrations in rural and urban boys from 16 countries. Atherosclerosis. 36:529–537.
      OpenUrlCrossRefPubMed
    17. ↵
      1. Halfon ST,
      2. Rifkind BM,
      3. Harlap S,
      4. et al.
      (1982) Plasma lipids and lipoproteins in adult Jews of different origins: the Jerusalem Lipid Research Clinic Prevalence Study. Isr J Med Sci. 18:1113–1120.
      OpenUrlPubMed
    18. ↵
      World Health Organization. World Health Statistics Annual, 1986. Geneva, Switzerland: World Health Organization; 1986
    19. ↵
      World Health Organization. World Health Statistics Annual, 1987. Geneva, Switzerland: World Health Organization; 1987
    20. ↵
      World Health Organization. World Health Statistics Annual, 1988. Geneva, Switzerland: World Health Organization; 1988
    21. ↵
      1. Halfon ST,
      2. Eisenberg S,
      3. Tamir D,
      4. Stein Y
      (1983) Risk factors for coronary heart disease among Jerusalem school children: preliminary findings. Prev Med. 12:421–429.
      OpenUrlCrossRefPubMed
    22. ↵
      1. National Center for Health Statistics—National Heart, Lung, and Blood Institute Collaborative Lipid Group
      (1987) Trends in serum cholesterol levels among US adults aged 20 to 74 years: data from the National Health and Nutrition Examination Surveys, 1960 to 1980. JAMA. 257:937–942.
      OpenUrlCrossRefPubMed
    23. ↵
      1. Knuiman JT,
      2. West CE,
      3. Burema J
      (1982) Serum total and high density lipoprotein cholesterol concentrations and body mass index in adult men from 13 countries. Am J Epidemiol. 116:631–642.
      OpenUrlPubMed
    24. ↵
      1. Multiple Risk Factor Intervention Trial Research Group
      (1990) Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a priori hypotheses of the trial. JAMA. 263:1795–1801.
      OpenUrlCrossRefPubMed
    25. ↵
      1. The Lipid Research Clinics Coronary Primary Prevention Trial Results
      (1984) II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 251:365–374.
      OpenUrlCrossRefPubMed
    26. ↵
      1. The Lipid Research Clinics Coronary Primary Prevention Trial Results
      (1984) I. Reduction in incidence of coronary heart disease. JAMA. 251:351–364.
      OpenUrlCrossRefPubMed
    27. ↵
      1. Yusuf S,
      2. Wittes J,
      3. Friedman L
      (1988) Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA. 260:2259–2263.
      OpenUrlCrossRefPubMed
    28. ↵
      1. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvistatin Survival Study(4S)
      (1994) Lancet. 344:1383–1389.
      OpenUrlCrossRefPubMed
    29. ↵
      1. Shepherd J,
      2. Cobbe SM,
      3. Ford I,
      4. et al.
      (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 333:1301–1307.
      OpenUrlCrossRefPubMed
    30. ↵
      1. The Writing Group for the DISC Collaborative Research Group
      (1995) Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated LDL lipoprotein cholesterol. JAMA. 273:1429–1435.
      OpenUrlCrossRefPubMed
      1. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentration and smoking: a preliminary report from the Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group
      (1990) JAMA. 264:3018–3024.
      OpenUrlCrossRefPubMed
    31. ↵
      1. Schrott HG,
      2. Clarke WR,
      3. Abrahams P,
      4. Wiebe DA,
      5. Lauer RM
      (1982) Coronary artery disease mortality in relatives of hypertriglyceridemic school children: the Muscatine study. Circulation. 65:300–305.
      OpenUrlAbstract/FREE Full Text
    32. ↵
      1. Moll PP,
      2. Sing CF,
      3. Weidman WH,
      4. et al.
      (1983) Total cholesterol and lipoproteins in school children: prediction of coronary heart disease in adult relatives. Circulation. 67:127–134.
      OpenUrlAbstract/FREE Full Text
    33. ↵
      1. Beaty TH,
      2. Self SG,
      3. Chase GA,
      4. Kwiterovich PO
      (1983) Assessment of variance components models on pedigrees using cholesterol, low-density, and high-density lipoprotein measurements. Am J Med Genet. 16:117–129.
      OpenUrlCrossRefPubMed
    34. ↵
      1. Van Natta PA,
      2. Jenkins JA,
      3. Chase GA,
      4. Alvaro K,
      5. Bachorik PS,
      6. Kwiterovich PO Jr
      (1981) The East Baltimore Study. II. Familial aggregation of plasma lipid levels in juveniles in a black inner-city population. Am J Epidemiol. 114:385–397.
      OpenUrlPubMed
    35. ↵
      1. Boehnke M,
      2. Moll PP,
      3. Lange K,
      4. Weidman WH,
      5. Kottke BA
      (1986) Univariate and bivariate analyses of cholesterol and triglyceride levels in pedigrees. Am J Med Genet. 23:775–792.
      OpenUrlCrossRefPubMed
    36. ↵
      1. Goldstein JL,
      2. Schrott HG,
      3. Hazzard WR,
      4. Bierman EL,
      5. Motulsky AG
      (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 52:1544–1568.
      OpenUrlCrossRefPubMed
    37. ↵
      1. Kwiterovich PO Jr
      (1989) Pediatric implications of heterozygous familial hypercholesterolemia: screening and dietary treatment. Arteriosclerosis. 9:I111–I120.
      OpenUrl
    38. ↵
      1. Clark DA,
      2. Allen MF,
      3. Wilson FH
      (1967) Longitudinal study of serum lipids: 12-year report. Am J Clin Nutr. 20:743–752.
      OpenUrlAbstract
    39. ↵
      1. Clarke WR,
      2. Schrott HG,
      3. Leaverton PE,
      4. Connor WE,
      5. Lauer RM
      (1978) Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation. 58:626–634.
      OpenUrlAbstract/FREE Full Text
    40. ↵
      1. Frerichs RR,
      2. Webber LS,
      3. Voors AW,
      4. Srinivasan SR,
      5. Berenson GS
      (1979) Cardiovascular disease risk factor variables in children at two successive years: the Bogalusa heart study. J Chronic Dis. 32:251–262.
      OpenUrlCrossRefPubMed
    41. ↵
      1. Laskarzewski P,
      2. Morrison JA,
      3. deGroot I,
      4. et al.
      (1979) Lipid and lipoprotein tracking in 108 children over a four-year period. Pediatrics. 64:584–591.
      OpenUrlAbstract/FREE Full Text
    42. ↵
      1. Freedman DS,
      2. Shear CL,
      3. Srinivasan SR,
      4. Webber LS,
      5. Berenson GS
      (1985) Tracking of serum lipids and lipoproteins in children over an 8-year period: the Bogalusa heart study. Prev Med. 14:203–216.
      OpenUrlCrossRefPubMed
    43. ↵
      1. Orchard TJ,
      2. Donahue RP,
      3. Kuller LH,
      4. Hodge PN,
      5. Drash AL
      (1983) Cholesterol screening in childhood: does it predict adult hypercholesterolemia? The Beaver County experience. J Pediatr. 103:687–691.
      OpenUrlCrossRefPubMed
    44. ↵
      1. Lauer RM,
      2. Lee J,
      3. Clarke WR
      (1988) Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine study. Pediatrics. 82:309–318.
      OpenUrlAbstract/FREE Full Text
    45. ↵
      1. Lauer RM,
      2. Clarke WR
      (1990) Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia. The Muscatine study. JAMA. 264:3034–3038.
      OpenUrlCrossRefPubMed
    46. ↵
      Nationwide Food Consumption Survey, Continuing Survey of Food Intakes by Individuals: Women 19–50 Years and Their Children 1–5 Years. Hyattsville, MD: US Dept of Agriculture, Human Nutrition Information Service, Nutrition Monitoring Division; 1986
    47. ↵
      Nationwide Food Consumption Survey, Continuing Survey of Food Intakes by Individuals: Men 19–50 Years. Hyattsville, MD: US Dept of Agriculture, Human Nutrition Information Service, Nutrition Monitoring Division; 1985
    48. ↵
      McDowell MA, Briefel RR, Alaimo K, et al. Energy and Macronutrient Intakes of Persons Ages 2 Months and Over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988–91. Hyattsville, MD: National Center for Health Statistics; Advance Data from Vital and Health Statistics; No. 255; 1994
    49. ↵
      National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. Bethesda, MD: National Cholesterol Education Program; 1990
    50. ↵
      1. Quivers ES,
      2. Driscoll DJ,
      3. Garvey CD,
      4. et al.
      (1992) Variability in response to a low-fat low-cholesterol diet in children with elevated LDL–cholesterol levels. Pediatrics. 89:925–929.
      OpenUrlAbstract/FREE Full Text
    51. ↵
      National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol in Children and Adolescents. Bethesda, MD: National Cholesterol Education Program; 1991
    • Copyright © 1998 American Academy of Pediatrics
    PreviousNext
    Back to top

    Advertising Disclaimer »

    In this issue

    Pediatrics
    Vol. 101, Issue 1
    1 Jan 1998
    • Table of Contents
    • Index by author
    View this article with LENS
    PreviousNext
    Email Article

    Thank you for your interest in spreading the word on American Academy of Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Cholesterol in Childhood
    (Your Name) has sent you a message from American Academy of Pediatrics
    (Your Name) thought you would like to see the American Academy of Pediatrics web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Request Permissions
    Article Alerts
    Log in
    You will be redirected to aap.org to login or to create your account.
    Or Sign In to Email Alerts with your Email Address
    Citation Tools
    Cholesterol in Childhood
    Committee on Nutrition
    Pediatrics Jan 1998, 101 (1) 141-147; DOI: 10.1542/peds.101.1.141

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Cholesterol in Childhood
    Committee on Nutrition
    Pediatrics Jan 1998, 101 (1) 141-147; DOI: 10.1542/peds.101.1.141
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts
    • Table of Contents

    Jump to section

    • Article
      • Abstract
      • DIET AND ATHEROSCLEROSIS
      • CLINICAL TRIALS
      • SIGNIFICANCE OF BLOOD CHOLESTEROL LEVELS IN CHILDREN AND ADOLESCENTS
      • STRATEGIES TO LOWER CHOLESTEROL LEVELS IN CHILDREN AND ADOLESCENTS
      • THE INDIVIDUALIZED APPROACH
      • CONCLUSION
      • Footnotes
      • REFERENCES
    • Figures & Data
    • Info & Metrics
    • Comments

    Related Articles

    • ERRATUM
    • Lipid Screening and Cardiovascular Health in Childhood
    • PubMed
    • Google Scholar

    Cited By...

    • Infancy-Onset Dietary Counseling of Low-Saturated-Fat Diet Improves Insulin Sensitivity in Healthy Adolescents 15-20 Years of Age: The Special Turku Coronary Risk Factor Intervention Project (STRIP) study
    • Diagnostic Performance of Hemoglobin A1c for Prediabetes and Association With Cardiometabolic Risk Factors in Chinese Adolescents Without Diabetes
    • Cholesterol Screening: Primary Prevention Comes of Age
    • Metabolic Risk and Health Behaviors in Minority Youth at Risk for Type 2 Diabetes
    • Universal Versus Targeted Blood Cholesterol Screening Among Youth: The CARDIAC Project
    • Vitamin D Status Is Modestly Associated with Glycemia and Indicators of Lipid Metabolism in French-Canadian Children and Adolescents
    • Using BMI to Determine Cardiovascular Risk in Childhood: How Do the BMI Cutoffs Fare?
    • The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
    • Trends in the Prevalence of Chronic Medication Use in Children: 2002-2005
    • Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia
    • Lipid Screening and Cardiovascular Health in Childhood
    • Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study
    • Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force
    • Prevalence of cardiovascular disease risk in Ontario adolescents
    • The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions
    • Natural History and Risk Factors for Microalbuminuria in Adolescents With Type 1 Diabetes: A longitudinal study.
    • Utility of Childhood Non-High-Density Lipoprotein Cholesterol Levels in Predicting Adult Dyslipidemia and Other Cardiovascular Risks: The Bogalusa Heart Study
    • Sensitivity and Specificity of Pediatric Lipid Determinations for Adult Lipid Status: Findings From the Princeton Lipid Research Clinics Prevalence Program Follow-up Study
    • Current and Future Treatment of Metabolic Syndrome and Type 2 Diabetes in Children and Adolescents
    • Effect of Obesity and High Blood Pressure on Plasma Lipid Levels in Children and Adolescents
    • Dietary Fat Intake Is Associated with Psychosocial and Cognitive Functioning of School-Aged Children in the United States
    • Cholesterol Intake Is Associated with Lecithin Intake in Japanese People
    • Obesity and risk factors for the metabolic syndrome among low-income, urban, African American schoolchildren: the rule rather than the exception?
    • Obese Children Who Are Referred to the Pediatric Endocrinologist: Characteristics and Outcome
    • If It's Not Worth Doing, It's Not Worth Doing Well
    • Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues
    • Usefulness of the American Academy of Pediatrics Recommendations for Identifying Youths With Hypercholesterolemia
    • Impact of Television Viewing Patterns on Fruit and Vegetable Consumption Among Adolescents
    • Prevention and Treatment of Type 2 Diabetes Mellitus in Children, With Special Emphasis on American Indian and Alaska Native Children
    • Prevention of Pediatric Overweight and Obesity
    • Management of Dyslipidemia in Children and Adolescents With Diabetes
    • Epidemic of Diabetic and Nondiabetic Renal Disease among the Zuni Indians: The Zuni Kidney Project
    • Distribution of Fasting Plasma Insulin, Free Fatty Acids, and Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents
    • Distribution and Correlates of Non-High-Density Lipoprotein Cholesterol in Children: The Bogalusa Heart Study
    • Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
    • Diet Quality, Nutrient Intake, Weight Status, and Feeding Environments of Girls Meeting or Exceeding Recommendations for Total Dietary Fat of the American Academy of Pediatrics
    • Cholesterol Guidelines Debate
    • Summary
    • Developing and implementing food-based dietary guidance for fat in the diets of children
    • Nutritional Guidance Is Needed During Dietary Transition in Early Childhood
    • Cholesterol Screening in Children and Adolescents
    • Impact of Dietary Fat and Fiber Intake on Nutrient Intake of Adolescents
    • The Role of Dietary Fat in Child Nutrition and Development: Summary of an ASNS Workshop
    • Summary of a Scientific Conference on Preventive Nutrition: Pediatrics to Geriatrics
    • The Relation of Overweight to Cardiovascular Risk Factors Among Children and Adolescents: The Bogalusa Heart Study
    • Dietary Guidelines for Children: Where Are We Heading?
    • Google Scholar

    More in this TOC Section

    • Exposure to Nontraditional Pets at Home and to Animals in Public Settings: Risks to Children
    • Medical Emergencies Occurring at School
    • Disaster Planning for Schools
    Show more AMERICAN ACADEMY OF PEDIATRICS

    Similar Articles

    Subjects

    • Cardiology
      • Cardiology
    • Journal Info
    • Editorial Board
    • Editorial Policies
    • Overview
    • Licensing Information
    • Authors/Reviewers
    • Author Guidelines
    • Submit My Manuscript
    • Open Access
    • Reviewer Guidelines
    • Librarians
    • Institutional Subscriptions
    • Usage Stats
    • Support
    • Contact Us
    • Subscribe
    • Resources
    • Media Kit
    • About
    • International Access
    • Terms of Use
    • Privacy Statement
    • FAQ
    • AAP.org
    • shopAAP
    • Follow American Academy of Pediatrics on Instagram
    • Visit American Academy of Pediatrics on Facebook
    • Follow American Academy of Pediatrics on Twitter
    • Follow American Academy of Pediatrics on Youtube
    • RSS
    American Academy of Pediatrics

    © 2021 American Academy of Pediatrics